Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-12-01T01:58:59.145Z Has data issue: false hasContentIssue false
  • English
  • Français

Brief Report: Nosocomial Infection Rates in a Cancer Treatment Center

Published online by Cambridge University Press:  02 January 2015

Gayle V. Robinson ,
Bernard R. Tegtmeier  and
John A. Zaia
Gayle V. Robinson*
Affiliation:
Infection Control Office, Duarte, California Clinical Microbiology Section, Division of Clinical Pathology, Duarte, California Infectious Disease Section, Division of Pediatrics, Duarte, California City of Hope National Medical Center, Duarte, California
Bernard R. Tegtmeier
Affiliation:
Infection Control Office, Duarte, California Clinical Microbiology Section, Division of Clinical Pathology, Duarte, California Infectious Disease Section, Division of Pediatrics, Duarte, California City of Hope National Medical Center, Duarte, California
John A. Zaia
Affiliation:
Infection Control Office, Duarte, California Clinical Microbiology Section, Division of Clinical Pathology, Duarte, California Infectious Disease Section, Division of Pediatrics, Duarte, California City of Hope National Medical Center, Duarte, California
*
Infection Control Coordinator, City of Hope National Medical Center, Duarte, CA 91010
Get access Rights & Permissions [Opens in a new window]

Abstract

This report describes the results of a prospective study of nosocomial infection in 7,714 patients hospitalized during a 24-month period at a cancer treatment center. An overall nosocomial infection rate of 9.3% was observed with site-specific infection rates of 2.6% for urinary tract, 1.9% for surgical wound, 2.2% for bacteremia and 1.9% for respiratory tract infection. Within specific patient groups, the overall nosocomial infection rates observed were: 8.2% in medical patients, 14.9% in surgical patients and 1.5% in pediatric patients. Despite the markedly elevated nosocomial infection rate in surgical patients (P < 0.001), surgical wound infection rates were not unlike those observed in general hospitals: clean—2.4%, clean contaminated—5.8%, contaminated—13.2%, and dirty—11.8%. These observations provide evidence that institutions which provide medical care predominantly for cancer patients can expect to observe higher nosocomial infection rates than general care hospitals.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 5 , Issue 6 , June 1984 , pp. 289 - 294
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1984

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Ketchel, SJ, Rodriguez, V, Acute infections in cancer patients. Semin Oncol 1978;5:167–168.Google ScholarPubMed
2.Centers for Disease Control National Nosocomial Infections Study Report, 1977, Atlanta, Centers for Disease Control, 1979.Google Scholar
3.Outline for Surveillance and Control of Nosocomial Infections. US Dept of Health and Human Services, Atlanta, Centers for Disease Control, 1972.Google Scholar
4.Cruse, P, Wound infection surveillance. Rev Infect Dis 1981;3:734–737.CrossRefGoogle ScholarPubMed
5.Fleiss, JL, Statistical Methods for Rates and Proportions,ed 2. New York, John Wiley and Sons, 1981.Google Scholar
6.Haley, RW, Culver, DH, Emori, TG, et al: Progress report on the evaluation of the efficacy of infection surveillance & control programs, in Dixon, RL (ed): Nosocomial Infections. New York, York Medical Books, 1981.Google ScholarPubMed
7.Hooton, TM, Haley, RW, Culver, DH, et al: The joint associations of multiple risk factors with the occurrence of nosocomial infection, in Dixon, RL (ed): Nosocomial Infections. New York, York Medical Books, 1981, p 71.Google Scholar
8.Casazza, AR, Duvall, CP, Carbone, PP, Infections in lymphoma. JAMA 1966;197:710–718.CrossRefGoogle ScholarPubMed
9.Levine, AS, Schimpff, SC, Graw, RG, et al: Hematologic malignancies and other marrow failure states: Progress in the management of complicating infections. Semin Hematol 1974;11:141–201.Google ScholarPubMed
10.Winston, DJ, Gale, RP, Meyer, DV, et al: Infectious complications of human bone marrow transplantation. Medicine 1979;58:1–26.CrossRefGoogle ScholarPubMed
11.Dor, P, Klatersky, J, Prophylactic antibiotics in oral, pharyngeal and laryngeal surgery for cancer: A double blind study. Laryngoscope 1973;83:1992–1998.CrossRefGoogle Scholar
12.Becker, GD, Pareli, GJ, Cefozolin prophylaxis in head and neck cancer surgery. Ann Otol Rhinol Laryngol 1979;88:183–186.CrossRefGoogle Scholar
13.Budd, DC, Cochran, RC, Sturtz, DL, et al: Surgical morbidity after mastectomy operations. Am J Surg 1978;135:218–220.CrossRefGoogle ScholarPubMed
14.Wenzel, RP, Osterman, CA, Donowitz, LG, et al: Identification of procedure-related nosocomial infections in high risk patients. Rev Infect Dis 1981;3:701–707.CrossRefGoogle ScholarPubMed